title: Anti-allodynic effects of peripheral delta opioid receptors in neuropathic pain.
abstract: The analgesic effects of local administration of opioid agonists into peripheral tissues in alleviating pain have been well documented in both clinical and preclinical studies, although few studies have examined their effects in neuropathic pain. In this study, we investigated the anti-allodynic effects of peripherally acting delta opioid receptor (DOR) agonists in a rat model of neuropathic pain. Peripheral nerve injury (PNI) produced a time-dependent decrease in mechanical withdrawal thresholds that was attenuated by local administration into the hind paw of either morphine or the DOR agonist deltorphin II. Using Western blotting techniques, no change in DOR protein expression was detected in DRG ipsilateral to the site of injury compared to contralateral. However, an up-regulation of DOR protein was found in neuropathic DRG compared to sham, suggesting that there may be a bilateral increase in the expression of DOR following PNI. Results obtained from immunohistochemical studies confirmed up-regulation in small and large DRG neurons in neuropathic compared to sham animals. Additionally, there was an increase in DOR protein within the ipsilateral sciatic nerve of neuropathic animals compared to sham and contralateral neuropathic conditions indicating the occurrence of receptor trafficking to the site of injury. Taken together, our findings suggest that functional peripheral DORs are present in sensory neurons following PNI and validate the development of selective DOR agonists for alleviating neuropathic pain.
authors.affiliation: Department of Pharmacology and Toxicology, Queen's University, Kingston, Ont., Canada K7L 3N6.
authors.forename: Noufissa
authors.initials: N
authors.lastname: Kabli
authors.forename: Catherine Marie
authors.initials: CM
authors.lastname: Cahill
mesh_terms: D000818:Animals; D004305:Dose-Response Relationship, Drug; D005727:Ganglia, Spinal / Q000187:drug effects / Q000503:physiopathology*; D006941:Hyperesthesia / Q000139:chemically induced / Q000378:metabolism*; D008297:Male; D009292:Narcotic Antagonists / Q000008:administration & dosage*; D009437:Neuralgia / Q000139:chemically induced / Q000378:metabolism*; D009475:Neurons, Afferent / Q000187:drug effects / Q000378:metabolism*; D017288:Pain Threshold / Q000187:drug effects*; D051381:Rats; D017207:Rats, Sprague-Dawley; D017465:Receptors, Opioid, delta / Q000378:metabolism*
chemical_list: D009292:Narcotic Antagonists; D017465:Receptors, Opioid, delta